Search
for
Sort by
Research 301–330 of 1000+
- Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report
- P151 A multicentre real-world evaluation of ritlecitinib in severe alopecia areata: patient-reported outcome measures
- Real-World Ritlecitinib Treatment of Severe Alopecia Areata in the United States: Patient Characteristics and Physician Satisfaction According to a Secondary Database Analysis
- Psychosomatic aspects of alopecia areata
- A Current Diagnostic and Therapeutic Challenge: Tinea Capitis
- Pressure alopecias: A review
- Alopecia areata (AA)
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients
- Adis Summary of Research: Improvement in measures of quality of life and symptoms of anxiety and depression in patients with severe alopecia areata achieving sustained scalp hair regrowth with baricitinib
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- Vitamin D and the Skin: A Review for Dermatologists
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Post Herpetic Itch Leading to Frictional Alopecia of Eyebrow and Scalp-A Hitherto Undescribed Phenomenon
- Tofacitinib therapy for children with severe alopecia areata
- Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Long‐Term Real‐World Outcomes of Baricitinib in Severe Alopecia Areata: A 104‐Week Retrospective Analysis From a Single Institute
- Hidradenitis Suppurativa in Children and Adolescents: A Review of Treatment Options
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Table 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region
- OTITIS EXTERNA AND OTITIS MEDIA IN CATS IN ASSIUT: A RETROSPECTIVE STUDY OF PRESENTING SIGNS, CAUSES, DIAGNOSIS AND TREATMENT
- Novel association of trichothiodystrophy with autoimmune thyroiditis and autoimmune hemolytic anemia: A case report